Tibsovo 250 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FCY9N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,100
Award facts
- Contract value 100% obligated
- $23,100.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,100.31 to AmerisourceBergen Drug Corp for the supply of TIBSOVO (ivosidenib) 250 mg tablets (60-count packages) on January 12, 2026, with an ultimate completion date of February 3, 2026. This is a firm fixed-price, non-set-aside contract with place of performance in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. This delivery order for TIBSOVO, an oncology medication, reflects the company's established capability to supply specialized pharmaceutical products through the DLA's Medical Supply Chain. The non-set-aside competitive award demonstrates that AmerisourceBergen successfully competed against other qualified vendors to meet the government's pharmaceutical procurement requirements for this specific medication delivery.
Quick answers
Who was awarded contract SPE2DR26FCY9N?
SPE2DR26FCY9N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FCY9N worth?
The government has obligated $23,100 on SPE2DR26FCY9N.
Is contract SPE2DR26FCY9N an order under another contract?
Yes. SPE2DR26FCY9N is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCY9N competed?
The extent of competition for SPE2DR26FCY9N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award